We are live on ! Find out more
BHC icon

Bausch Health

556 hedge funds and large institutions have $57.6B invested in Bausch Health in 2015 Q1 according to their latest regulatory filings, with 118 funds opening new positions, 162 increasing their positions, 217 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more first-time investments, than exits

New positions opened: 118 | Existing positions closed: 54

41% more capital invested

Capital invested by funds: $40.9B → $57.6B (+$16.8B)

16% more funds holding in top 10

Funds holding in top 10: 7587 (+12)

12% more funds holding

Funds holding: 496556 (+60)

0.5% less ownership

Funds ownership: 84.97%84.48% (-0.5%)

25% less repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 217

45% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $2.22B

Holders
556
Holders Change
+60
Holders Change %
+12.1%
% of All Funds
14.81%
Holding in Top 10
87
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+16%
% of All Funds
2.32%
New
118
Increased
162
Reduced
217
Closed
54
Calls
$1.23B
Puts
$2.22B
Net Calls
-$989M
Net Calls Change
-$726M
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
326
TIAA CREF Investment Management
New York
$2.98M -$126M -713,015 -98%
MCM
327
Murphy Capital Management
New Jersey
$2.96M -$62.1K -350 -2%
YIA
328
YHB Investment Advisors
Connecticut
$2.89M -$93.1K -525 -3%
TPCM
329
Three Peaks Capital Management
Colorado
$2.89M +$630K +3,549 +32%
DL
330
Delta Lloyd
Netherlands
$2.88M +$1.95K +11 +0.1%
PLCM
331
Plymouth Lane Capital Management
New York
$2.78M +$2.48M +14,000 New
AP
332
Appleton Partners
Massachusetts
$2.67M -$156K -880 -6%
LPL Financial
333
LPL Financial
California
$2.66M +$719K +4,053 +43%
DCM
334
Driehaus Capital Management
Illinois
$2.62M -$4.44M -25,020 -65%
Commonwealth Equity Services
335
Commonwealth Equity Services
Massachusetts
$2.6M +$15.6K +88 +0.7%
AIG
336
American International Group
New York
$2.49M +$632K +3,563 +40%
RFC
337
Regions Financial Corp
Alabama
$2.48M -$746K -4,203 -25%
Mirae Asset Global Investments
338
Mirae Asset Global Investments
South Korea
$2.46M +$542K +3,056 +33%
EGM
339
Engineers Gate Manager
New York
$2.45M +$532K +2,998 +32%
IA
340
Icon Advisers
Colorado
$2.44M
H
341
Hexavest
Quebec, Canada
$2.44M
PIM
342
Partner Investment Management
California
$2.38M -$10.7M -60,519 -83%
CCM
343
Condor Capital Management
New Jersey
$2.31M +$494K +2,785 +32%
SI
344
Scharf Investments
California
$2.24M -$85.7K -483 -4%
TRCT
345
Tower Research Capital (TRC)
New York
$2.2M +$1.45M +8,162 +1,302%
CSS
346
Cubist Systematic Strategies
Connecticut
$2.15M +$462K +2,604 +32%
SAM
347
Silvercrest Asset Management
New York
$2.12M
BBHC
348
Brown Brothers Harriman & Co
New York
$2.09M +$1.87M +10,526 New
AIM
349
Artemis Investment Management
United Kingdom
$2.09M +$1.86M +10,504 New
Group One Trading
350
Group One Trading
Illinois
$2.07M -$1.59M -8,947 -46%

BHC Hedge Fund Activity: Q1 2015 in Review

556 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2015, worth a combined $57.6B — up 41% from $40.9B a quarter earlier.

Buyers outnumbered sellers: 118 funds opened new BHC positions and 54 closed out — a net gain of 64 holders — while 162 added to existing stakes and 217 trimmed.

The largest buyer was Pershing Square Capital Management, opening a new position worth an estimated $3.45B. The largest seller was Viking Global Investors, cutting an estimated $890M.

  • 556 institutional investors held Bausch Health (BHC) as of Q1 2015, up from 496 in Q4 2014.
  • Funds reported $57.6B of Bausch Health stock for Q1 2015, up 41% quarter-over-quarter.
  • 118 funds opened new Bausch Health positions in Q1 2015 and 54 closed out, a net change of +64 holders.
  • The largest Bausch Health buyer in Q1 2015 was Pershing Square Capital Management, an estimated $3.45B added.
  • The largest Bausch Health seller in Q1 2015 was Viking Global Investors, an estimated $890M sold.

Based on aggregated 13F filings for Q1 2015.